ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,549.00
      1.08%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Verrica Parmaceuticals Inc (VRCA)

      7. Verrica Parmaceuticals Inc (VRCA) News

      VRCA

      Verrica Parmaceuticals (VRCA)

      Verrica Parmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VRCA
      DateTimeSourceHeadlineSymbolCompany
      02/21/20238:58AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
      02/14/20232:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
      02/02/20234:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
      01/24/20237:59AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
      12/20/20226:10AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRCAVerrica Parmaceuticals Inc
      12/19/20224:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
      11/14/20226:15AMTipRanksH.C. Wainwright Remains a Buy on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      11/10/20228:48PMTipRanksRBC Capital Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      11/07/20225:23PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:VRCAVerrica Parmaceuticals Inc
      11/07/20224:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRCAVerrica Parmaceuticals Inc
      11/07/20224:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
      11/07/20224:05PMGlobeNewswire Inc.Verrica Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
      09/14/20228:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
      08/31/20224:30PMGlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
      08/12/20226:25AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      08/11/20224:35PMTipRanksNeedham Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      08/11/20228:07AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRCAVerrica Parmaceuticals Inc
      08/11/20227:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
      08/05/202212:18PMPR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
      08/03/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      08/01/20227:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Announces Start of Phase 3 Trial of VP-102 for the Treatment of Molluscum Contagiosum by Torii Pharmaceutical Co., Ltd. in JapanNASDAQ:VRCAVerrica Parmaceuticals Inc
      07/29/20225:45AMPR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/27/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/22/20225:45AMPR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/20/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/15/20224:16PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/15/20225:45AMPR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/13/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/11/20225:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
      07/08/202210:12PMTipRanksRBC Capital Maintains Their Hold Rating on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:VRCA